Results 151 to 160 of about 2,101,015 (298)
Advancements in Bimetallic Metal-Organic Frameworks for Oral Medicine. [PDF]
Yang Y +5 more
europepmc +1 more source
Abstracts from the X International congress of the Spanish Society of Oral Medicine : Cadiz, Spain, 11-13 Jun 2009 [PDF]
Spanish Society of Oral Medicine
core
Sex Differences in Medication Discontinuation in Axial Spondyloarthritis
Objective We examined sex differences in medication discontinuation among patients with axial spondyloarthritis (axSpA) initiating tumor necrosis factor inhibitors (TNFi), interleukin‐17 inhibitors (IL‐17i), or JAK inhibitors (JAKi). Methods Using data from the Rheumatology Informatics System for Effectiveness (RISE) Registry (2003–2025), we assessed ...
Rachael Stovall +9 more
wiley +1 more source
Editorial: Recent advances in oral medicine in dogs and cats. [PDF]
Anderson J, Soltero-Rivera M.
europepmc +1 more source
Objective Sjögren's disease is an autoimmune disorder that can impact multiple organ systems, including the peripheral nervous system (PNS). PNS manifestations, which can exist concurrently, include mononeuropathies, polyneuropathies, and autonomic nervous system neuropathies.
Anahita Deboo +88 more
wiley +1 more source
Implementation of an artificial intelligence-powered training platform in oral medicine and pathology education: a comparative study. [PDF]
Quah B, Chia NWC, Huynh MKH, Islam I.
europepmc +1 more source
Objective We developed a novel electronic health record sidecar application to visualize key rheumatoid arthritis (RA) outcomes, including disease activity, physical function, and pain, via a patient‐facing graphical interface designed for use during outpatient visits (“RA PRO dashboard”).
Gabriela Schmajuk +16 more
wiley +1 more source
Advancements in Microfluidic Organ-on-a-chip for Oral Medicine. [PDF]
Fan S, Ge Y, Li B, Liu P, Liu X.
europepmc +1 more source
On the Role of Psychoneuroimmunology in Oral Medicine. [PDF]
Seizer L, Schubert C.
europepmc +1 more source
Objective The objective of this study was to describe the longitudinal disease course and pulmonary outcomes of North American patients with melanoma differentiation–associated protein 5 (MDA5) antibody–associated dermatomyositis (DM). Methods Thirty patients with MDA5 antibody–associated DM were identified in a single‐center longitudinal cohort of 352
Jenice X. Cheah +8 more
wiley +1 more source

